Results 91 to 100 of about 21,695 (218)

Instantaneous Wave-Free Ratio-Guided Interventions in Side Branches Improve Results in Bifurcation Lesions Compared to Conventional Techniques

Journal of Interventional Cardiology
Conclusions: iFR-guided side-branch intervention involving drug-eluting balloon inflation in bifurcation lesions was significantly better when compared to conventional interventions in terms of clinical and functional outcomes in patients with coronary ...
null Zia-ul-Sabah, Adel Masswary, Mohammed Alahmari, Abdullah Asiri, Javed Iqbal Wani, Humayoun Durrani, Shahid Aziz, Hafed Ahmad Alaskary, Ali Alqarni, Ayyub Ali Patel   +9 more
doaj   +1 more source

Progress in treatment by percutaneous coronary intervention: The stent of the future [PDF]

, 2013
First generation drug-eluting stents have considerably reduced in-stent restenosis and broadened the applications of percutaneous coronary interventions for the treatment of coronary artery disease.
Bourantas, C.V. (Christos), Diletti, R. (Roberto), Farooq, V. (Vasim), Garcia-Garcia, H.M. (Hector), Garg, S.A. (Scot), Gogas, B.D. (Bill), Kharlamov, A.N. (Alexander ), Muramatsu, T. (Takashi), Onuma, Y. (Yoshinobu), Ozaki, Y. (Yukio), Serruys, P.W.J.C. (Patrick), Zhang, Y. (Yaojun)   +11 more
core   +3 more sources

Numerical Investigation of a Dual‐Mode Shape Memory Alloy Stent Enabling Secondary Expansion via Focused Ultrasound: A Potential Strategy for Correcting In‐Stent Restenosis

Advanced Engineering Materials, Volume 28, Issue 6, 18 March 2026.
This study demonstrates a novel noninvasive strategy to treat in‐stent restenosis using focused ultrasound. A shape memory alloy stent initially expands at body temperature. If restenosis occurs, targeted ultrasound heating thermally actuates the stent, enabling a secondary expansion to reopen the blocked vessel, offering a potential alternative to ...
Stephen Asare, Lucinda Duncan, Josiah Owusu‐Danquah, Brian L. Davis   +3 more
wiley   +1 more source

Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon- expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial [PDF]

, 2002
BACKGROUND: The goal of this intravascular ultrasound investigation was to provide a more detailed morphological analysis of the local biological effects of the implantation of a sirolimus-eluting stent compared with an uncoated stent.
Abizaid, A.C. (Alexandre), Colombo, A. (Antonio), Degertekin, M. (Muzaffer), Feyter, P.J. (Pim) de, Guagliumi, G. (Giulio), Ligthart, J.M.R. (Jürgen), Lindeboom, W.K. (Wietze), Morice, M-C. (Marie-Claude), Serruys, P.W.J.C. (Patrick), Sousa, J.E. (Eduardo), Tanabe, K. (Kengo), Wijns, W. (William)   +11 more
core   +1 more source

OCTN2 Activates a Non‐Canonical Carnitine Metabolic Pathway to Promote MASH‐HCC Progression and Immunotherapy Resistance

Advanced Science, Volume 13, Issue 16, 18 March 2026.
In non‐MASH‐HCC, L‐carnitine promotes tumor progression primarily through its classical role in enhancing fatty acid oxidation (FAO). However, in MASH‐HCC, where FAO is markedly suppressed, L‐carnitine shifts from this canonical function to serve instead as an intracellular acetyl group buffer.
Chuqi Xia, Xiao Zhang, Jinze Li, Ning Xu, Sheng Hu, Qiyu Lu, Yuxuan Li, Taifu Xiao, Xu Li, Xue Wang, Kequan Xu, Daoming Liang   +11 more
wiley   +1 more source

TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation [PDF]

, 2003
BACKGROUND: The first clinical study of paclitaxel-eluting stent for de novo lesions showed promising results. We performed the TAXUS III trial to evaluate the feasibility and safety of paclitaxel-eluting stent for the treatment of in-stent restenosis ...
Backx, B.A.M.W. (Bianca), Degertekin, M. (Muzaffer), Disco, C. (Clemens), Feyter, P.J. (Pim) de, Giessen, W.J. (Wim) van der, Grube, E. (Eberhard), Ligthart, J.M.R. (Jürgen), Muller, R. (Ralf), Regar, E.S. (Eveline), Russell, M.E. (Mary), Selbach, G. (Guido), Serruys, P.W.J.C. (Patrick), Smits, P.C. (Pieter), Staberock, M. (Manfred), Tanabe, K. (Kengo)   +14 more
core   +1 more source

Drug-Eluting Balloon Angioplasty for Carotid In-Stent Restenosis

Journal of Endovascular Therapy, 2012
To report midterm results of 3 cases in which drug-eluting balloons (DEBs) were successfully used for the management of carotid in-stent restenosis (ISR).Two women aged 68 and 70 years and a 68-year-old man were referred to our institution for asymptomatic severe stenosis [>80% with peak systolic velocity (PSV) >300 cm/s by Doppler ultrasound ...
Liistro F, Porto I, Grotti S, Ventoruzzo G, Vergallo R, Bellandi G, Bolognese L   +6 more
openaire   +3 more sources

Redox‐Responsive Mitochondrial Delivery from Functionalized Vascular Stent Surfaces

Advanced NanoBiomed Research, Volume 6, Issue 3, March 2026.
A redox‐responsive stent surface is engineered to deliver functional mitochondria in response to oxidative stress. Upon exposure to reactive oxygen species, grafted mitochondria are released, internalized by vascular cells, and restore mitochondrial function under stress.
Fang Tang, Brandon C. Applewhite, Bowen Wang, Bin Jiang   +3 more
wiley   +1 more source

Drug-eluting coronary stents – focus on improved patient outcomes

Patient Related Outcome Measures, 2011
Zehra Jaffery, Amit Prasad, John H Lee, Christopher J WhiteDepartment of Cardiovascular Diseases, The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USAAbstract: The development of stent has been a major advance in
Jaffery Z, Prasad A, Lee JH, White CJ
doaj  

Modelling the impact of atherosclerosis on drug release and distribution from coronary stents [PDF]

, 2015
Although drug-eluting stents (DES) are now widely used for the treatment of coronary heart disease, there remains considerable scope for the development of enhanced designs which address some of the limitations of existing devices.
A Neubert, A Schiavone, A Seidlitz, A Tan, A Tellez, AD Levin, AR Tzafriri, AR Tzafriri, AR Tzafriri, AV Finn, B Semmling, BE Bierer, C Bernelli, C Yang, C. M. McKittrick, C. McCormick, CC O’Brien, CC O’Brien, CJ Creel, CP Naseerali, CW Hwang, CW Hwang, F Bozsak, G Douglas, G Mani, G Nakazawa, G Vairo, GE Ragkousis, GS Getz, H Hara, H Jia, HJ Kuh, HQ Zhao, IB Menown, J Guo, J Watt, J Wiebe, JF Granada, JL Fan, JM Weiler, K Milewski, K. G. Oldroyd, KB Biggs, KR Kamath, LE Perkins, M Kamberi, M Rattazzi, MA Ewart, MA Lovich, MF Prescott, P Coats, P Zunino, R Mongrain, R Virmani, RS Schwartz, RS Schwartz, S Hossainy, S McGinty, S McGinty, S McGinty, S McGinty, S Morlacchi, S Prabhu, S Simsekyilmaz, S. Kennedy, S. McGinty, SK Yazdani, SN Iqbal, T Inoue, T Watanabe, U Baber, VY Hoymans, W Khan, W Khan, W Zhu, WC Carlyle, WJ Denny, X Zhu, Y Nakashima, Y Wang, ZA Ali   +80 more
core   +2 more sources